Quantitative bone SPECT/CT: high specificity for identification of prostate cancer bone metastases
Abstract Purpose Bone scintigraphy with 99mTc-labeled diphosphonates can identify prostate cancer bone metastases with high sensitivity, but relatively low specificity, because benign conditions such as osteoarthritis can also trigger osteoblastic reactions. We aimed to investigate the diagnostic pe...
Main Authors: | Flavian Tabotta, Mario Jreige, Niklaus Schaefer, Fabio Becce, John O. Prior, Marie Nicod Lalonde |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-12-01
|
Series: | BMC Musculoskeletal Disorders |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12891-019-3001-6 |
Similar Items
-
Standardized uptake values of 99mTc-MDP in normal vertebrae assessed using quantitative SPECT/CT for differentiation diagnosis of benign and malignant bone lesions
by: Na Qi, et al.
Published: (2021-02-01) -
Comparison of standardized uptake values between 99mTc-HDP SPECT/CT and 18F-NaF PET/CT in bone metastases of breast and prostate cancer
by: Samuli Arvola, et al.
Published: (2019-01-01) -
The clinical value of xSPECT/CT Bone versus SPECT/CT. A prospective comparison of 200 scans
by: Iain Duncan, et al.
Published: (2018-03-01) -
Bone SPECT-based segmented attenuation correction for quantitative analysis of bone metastasis (B-SAC): comparison with CT-based attenuation correction
by: Tadaki Nakahara, et al.
Published: (2019-03-01) -
Does quantification have a role to play in the future of bone SPECT?
by: James C. Ross, et al.
Published: (2019-05-01)